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Summary
Preterm birth (PTB) is a global problem with a high incidence in the developing world. Relaxin 
(RLN) has classically been associated with parturition, but its role(s) in the human have been 
difficult to determine. For the first time, we bring together the systemic (ovarian) and auto-
crine/paracrine (intrauterine) sources of RLN, in an attempt to understand how RLN contrib-
utes to PTB in women.
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The first global report on PTB uses data from 184 countries and more than 400 
member organizations (Howson et al., 2012). If these babies survive, they often have 
lasting disabilities and as adults have an increased risk of major diseases. PTB is a 
complex multifactorial disease. There are two main sources of RLN in human preg-
nancy, the ovary (corpus luteum) and within the uterus, the decidua and placenta. 
The ovarian RLN enters the systemic circulation, targets the decidua/placenta via 
the blood, whereas decidual/placental RLN has only autocrine/paracrine actions, as 
shown in patients with ovum donation pregnancies, who have undetectable circulat-
ing RLN. Women destined to deliver preterm, have higher RLN levels in the second 
and third trimesters (Vogel et al., 2006). Indeed, elevation of circulating RLN has long 
been associated with PTB, for which there has been no explanation. In the choriode-
cidua, there is increased RLN gene expression in women with PPROM. Expression 
of the RLN receptor gene (RXFP1) is also increased in patients delivering at preterm 
(Bryant-Greenwood et al., 2007). 
In normal gestation, RLN in the circulation and intrauterine production are both 
low. We have shown that RLN can modulate the proinflammatory cytokines secreted 
from the decidual macrophages at the maternal-fetal interface. Low RLN levels, as 
in normal pregnancy were anti-inflammatory, but high levels were proinflammatory 
(Horton et al., 2011). If the RLN levels were sufficiently high, the avascular chorion 
could then also be a target and indeed, in vitro these cells show only a proinflamma-
tory response (Bryant-Greenwood et al, 2009).
Intrauterine infection is a major cause of PTB, it was important to know whether this 
affected RLN. Thus, intra-amniotic infusion of lipopolysaccharide (LPS) in monkeys and 
its incubation with human fetal membrane explants showed increased IL-6, but had no 
* Corresponding Author: Department of Obstetrics, Gynecology and Women’s Health, John A. Burns School of Medicine, 1319 
Punahou Street #824, Honolulu, Hawaii 96826, USA. Email: rochafg@gmail.com; Phone: 808 983-6000; Fax: 808 955-2174.
22 Frederico G. Rocha, Jaime S. Horton, Gillian D. Bryant-Greenwood
effect on RLN. On the other hand, because a proinflammatory intrauterine response is 
associated with PTB even in the absence of infection, we proposed that RLN alone may 
induce a local “sterile” inflammatory response. Using RLN treatment of human chorion 
cells and its intra-amniotic infusion in monkeys, IL-6 and IL-8 secretion were stimulat-
ed (Bryant-Greenwood et al., 2009). Therefore, although infection does not affect RLN, 
RLN alone is capable of producing a localized inflammatory response. However, elevated 
RLN can also augment the inflammatory response caused by a low level of intrauterine 
inflammation/infection (Horton et al., 2012). Thus, both ovarian and intrauterine RLN 
contribute to the pathophysiology of PTB.
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